However, few CFTR potentiators have been tested in the clinic and until recently only ivacaftor was approved for cystic fibrosis patient use (Becq et al., 2011; Ramsey et al., 2011; Ramsey & Welsh, 2017). This evidence concerns the gene CFTR and cystic fibrosis.